Letter to the Editor
Tuberculosis in the time of COVID-19: The successful results of treatment in Peru
Tuberculosis en época de COVID-19: los exitosos resultados del tratamiento en el Perú
Read
241
Timeswas read the article
45
Total PDF
196
Total HTML
Share statistics
array:24 [ "pii" => "S2529993X23000424" "issn" => "2529993X" "doi" => "10.1016/j.eimce.2022.03.019" "estado" => "S300" "fechaPublicacion" => "2023-02-01" "aid" => "2599" "copyright" => "Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica" "copyrightAnyo" => "2022" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Enferm Infecc Microbiol Clin. 2023;41:138-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0213005X22001008" "issn" => "0213005X" "doi" => "10.1016/j.eimc.2022.03.012" "estado" => "S300" "fechaPublicacion" => "2023-02-01" "aid" => "2599" "copyright" => "Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Enferm Infecc Microbiol Clin. 2023;41:138-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Editor</span>" "titulo" => "Tuberculosis en época de COVID-19: los exitosos resultados del tratamiento en el Perú" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "138" "paginaFinal" => "139" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Tuberculosis in the time of COVID-19: The successful results of treatment in Peru" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Roberto Alfonso Accinelli" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Roberto Alfonso" "apellidos" => "Accinelli" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2529993X23000424" "doi" => "10.1016/j.eimce.2022.03.019" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529993X23000424?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X22001008?idApp=UINPBA00004N" "url" => "/0213005X/0000004100000002/v1_202302051830/S0213005X22001008/v1_202302051830/es/main.assets" ] ] "itemSiguiente" => array:18 [ "pii" => "S2529993X22002805" "issn" => "2529993X" "doi" => "10.1016/j.eimce.2022.04.011" "estado" => "S300" "fechaPublicacion" => "2023-02-01" "aid" => "2578" "copyright" => "Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Enferm Infecc Microbiol Clin. 2023;41:139-40" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Is a viral panel testing worthy in our reality??" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "139" "paginaFinal" => "140" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "¿Vale la pena una prueba de panel viral en nuestra realidad?" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Felipe Rezende Caino de Oliveira, Letícia Valquer Trevisol, Raísa Aguiar Salvador, Werther Brunow de Carvalho" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Felipe Rezende Caino de" "apellidos" => "Oliveira" ] 1 => array:2 [ "nombre" => "Letícia Valquer" "apellidos" => "Trevisol" ] 2 => array:2 [ "nombre" => "Raísa Aguiar" "apellidos" => "Salvador" ] 3 => array:2 [ "nombre" => "Werther Brunow de" "apellidos" => "Carvalho" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529993X22002805?idApp=UINPBA00004N" "url" => "/2529993X/0000004100000002/v1_202302081247/S2529993X22002805/v1_202302081247/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S2529993X22002970" "issn" => "2529993X" "doi" => "10.1016/j.eimce.2022.12.006" "estado" => "S300" "fechaPublicacion" => "2023-02-01" "aid" => "2633" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Enferm Infecc Microbiol Clin. 2023;41:137-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Letter to the editor about “Pulmonary invasive fungal infection and rhinofacial cellulitis with paranasal sinus and orbital fossa invasion in an inmunocompromised patient”" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "137" "paginaFinal" => "138" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Carta al editor en relación a “Infección fúngica invasiva pulmonar y celulitis rinofacial con invasión de senos paranasales y fosa orbitaria en paciente inmunodeprimido”" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1182 "Ancho" => 1262 "Tamanyo" => 160013 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0120" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Endoscopic debridement image of invasive fungal rhinosinusitis due to <span class="elsevierStyleItalic">Aspergillus welwitschiae.</span> Solid arrow: lamina papyracea of left orbit. Dashed arrow: cribriform plate of anterior skull base. Asterisk: aspergilloma.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Juan Riestra-Ayora, Maria Garrote-Garrote, Cristina Molina-Quiros, Eduardo Martin-Sanz" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Juan" "apellidos" => "Riestra-Ayora" ] 1 => array:2 [ "nombre" => "Maria" "apellidos" => "Garrote-Garrote" ] 2 => array:2 [ "nombre" => "Cristina" "apellidos" => "Molina-Quiros" ] 3 => array:2 [ "nombre" => "Eduardo" "apellidos" => "Martin-Sanz" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0213005X22001574" "doi" => "10.1016/j.eimc.2022.06.015" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X22001574?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529993X22002970?idApp=UINPBA00004N" "url" => "/2529993X/0000004100000002/v1_202302081247/S2529993X22002970/v1_202302081247/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Tuberculosis in the time of COVID-19: The successful results of treatment in Peru" "tieneTextoCompleto" => true "saludo" => "Dear Editor," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "138" "paginaFinal" => "139" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Roberto Alfonso Accinelli" "autores" => array:1 [ 0 => array:4 [ "nombre" => "Roberto" "apellidos" => "Alfonso Accinelli" "email" => array:1 [ 0 => "roberto.accinelli@upch.pe2" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Cayetano Heredia, Lima, Peru" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Departamento de Medicina, Facultad de Medicina Alberto Hurtado, Universidad Peruana Cayetano Heredia, Lima, Peru" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Instituto de Investigaciones de la Altura, Lima, Peru" "etiqueta" => "c" "identificador" => "aff0015" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Tuberculosis en época de COVID-19: los exitosos resultados del tratamiento en el Perú" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">The authors of the letter to the editor entitled “Impact of the COVID-19 pandemic on tuberculosis in Peru: are we forgetting someone?”<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> state that a series of interventions should be implemented in our country, such as TB units, "to ensure all the necessary health measures to increase confidence among the population and reduce the risk of resistant forms of TB".</p><p id="par0010" class="elsevierStylePara elsevierViewall">They assert that Metropolitan Lima and Callao report 64% of tuberculosis (TB) cases, 79% are multi-drug resistant (MDR-TB), and 70% are extremely resistant (XDR-TB). No capital of any nation in the world has such incredibly high rates of MDR-TB and XDR-TB. What we read in document<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> is that Metropolitan Lima and Callao report 64% (19,860) of TB cases, 79% (1020) of MDR-TB cases, 70% (76) of XDR-TB cases and 45% of deaths, so comments are unnecessary.</p><p id="par0015" class="elsevierStylePara elsevierViewall">The COVID-19 pandemic led to an 18% drop worldwide in newly diagnosed TB cases from 2019 to 2020. In Peru, the drop was 26%,<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> lower than the figures for Gabon (80%), the Philippines (37%), Lesotho (35%) and Indonesia (31%), and similar to the figure for India (25%).<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> A state of national emergency was declared in Peru on 16 March 2020,<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> which lasted throughout the year with different restrictive measures, including quarantine of the entire population for 16 weeks,<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> a night curfew, only virtual classes allowed, the need for social distancing, prevention of meetings and closure of outpatient clinics. Despite that, Peru has the highest mortality<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> and orphan<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> rates associated with the disease in the world, meaning that the population, fearing contagion, either does not go or takes longer to go to health facilities when sick. For all these reasons, it is striking that in Peru there was a lower drop in cases than in countries where the restrictions were less severe.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Table 1 in the letter shows that for the year 2020 in Peru there was a 2.5% dropout rate among the sensitive cases and 5.7% among the resistant ones.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> These very low dropout rates, even lower than those of the previous three years (Table 1)<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> in Peru, have been achieved because the directly observed therapy (DOT), which takes place in the healthcare establishment (institutional DOT), was expanded to home DOT, in which healthcare workers go to the home, and to DOT with family support network, in which the therapy is administered by a family member, in addition to telemonitoring for follow-up.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">Coverage (approximated as notifications divided by incidence) of TB treatment in 2020 worldwide was 59%, down from 72% (uncertainty interval [UI]: 65–80%) in 2019. The most immediate consequence of the large drop in the number of people newly diagnosed with TB and on treatment was an increase in the number of deaths from TB in 2020 (+5.6%), reversing the annual reduction we had seen since 2005, with the total number of deaths returning to the level of 2017.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> We have to assume that there will be a spike in our disease rates in the coming years, the duration of which will depend on when our country returns to normal.</p><p id="par0030" class="elsevierStylePara elsevierViewall">Having exceeded the goals in TB control, in the 1990s, Peru left the TB80 group, which includes the countries that contribute 80% of the burden of the disease in the world. Our country's Tuberculosis Control Programme, now called Strategy, is rated as one of the best in the world.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> The letter sent to your journal has enabled us to make these comments and explain how we have worked during the pandemic with people affected by TB in Peru, where the numbers being diagnosed have reduced. Still, the high levels of cure achieved previously have been maintained.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Funding</span><p id="par0035" class="elsevierStylePara elsevierViewall">None.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Conflicts of interest</span><p id="par0040" class="elsevierStylePara elsevierViewall">None.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Funding" ] 1 => array:2 [ "identificador" => "sec0010" "titulo" => "Conflicts of interest" ] 2 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:10 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impact of the COVID-19pandemic on tuberculosis in Peru: Are we forgetting anyone?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J. Cardenas-Escalante" 1 => "J. Fernandez-Saucedo" 2 => "W.S. Cubas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.eimce.2021.07.008" "Revista" => array:7 [ "tituloSerie" => "Enferm Infecc Microbiol Clin (Engl Ed)" "fecha" => "2022" "volumen" => "40" "numero" => "January" "paginaInicial" => "46" "paginaFinal" => "47" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34764064" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Ministerio de Salud del Perú. RM N.◦ 247-2018/MINSA: Documento técnico: Plan de intervención de prevención y control de tuberculosis en Lima metro-politana y regiones priorizadas de Callao, Ica, La Libertad y Loreto, 2018–2020. https://cdn.www.gob.pe/uploads/document/file/187917/187412 R.M 247-2018-MINSA.PDF20180823-24725-behrrf.PDF." ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Ministerio de Salud del Perú. Sala situacional de tuberculosis. Available from: <a target="_blank" href="http://www.tuberculosis.minsa.gob.pe/DashboardDPCTB/Dashboard.aspx">http://www.tuberculosis.minsa.gob.pe/DashboardDPCTB/Dashboard.aspx</a>." ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Global tuberculosis report 2021" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "World Health Organization" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:3 [ "fecha" => "2021" "editorial" => "World Health Organization" "editorialLocalizacion" => "Ginebra" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Presidencia del Consejo de Ministros. Decreto Supremo que declara Estado de Emergencia Nacional por las graves circunstancias que afectan la vida de la Nación a consecuencia del brote del COVID-19. Normas legales. Diario El Peruano, 15 de marzo del 2020. Available from: <a target="_blank" href="https://busquedas.elperuano.pe/download/url/decreto-supremo-que-declara-estado-de-emergencia-nacional-po-decreto-supremo-n-044-2020-pcm-1864948-2">https://busquedas.elperuano.pe/download/url/decreto-supremo-que-declara-estado-de-emergencia-nacional-po-decreto-supremo-n-044-2020-pcm-1864948-2</a>." ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Presidencia del Consejo de Ministros. Decreto Supremo N◦094-2020-PCMque establece las medidas que debe observar la ciudadanía hacia una nueva convivencia social y prorroga el Estado de Emergencia Nacional por las graves circunstancias que afectan la vida de la Nación a consecuencia delCOVID-19. Normas legales. Diario El Peruano, 23 de mayo de 2020. Available from: <a target="_blank" href="https://busquedas.elperuano.pe/download/url/decreto-supremo-que-establece-las-medidas-que-debe-observar-decreto-supremo-n-094-2020-pcm-1866708-1">https://busquedas.elperuano.pe/download/url/decreto-supremo-que-establece-las-medidas-que-debe-observar-decreto-supremo-n-094-2020-pcm-1866708-1</a>." ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Letalidad por SARS-CoV-2 a nivel mundial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J.E. Díaz Pinzón" ] ] ] ] ] "host" => array:2 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Repert Med Cir" "fecha" => "2021" "volumen" => "30" "numero" => "Supl. 1" "paginaInicial" => "84" "paginaFinal" => "88" ] ] 1 => array:1 [ "WWW" => array:1 [ "link" => "https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1255/1725" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Global minimumestimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: A modelling study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.D. Hillis" 1 => "H.J. Unwin" 2 => "Y. Chen" 3 => "L. Cluver" 4 => "L. Sherr" 5 => "P.S. Goldman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(21)01253-8" "Revista" => array:7 [ "tituloSerie" => "Lancet" "fecha" => "2021" "volumen" => "398" "numero" => "July (10298)" "paginaInicial" => "391" "paginaFinal" => "402" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34298000" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Ministerio de Salud del Perú. RM N◦920-2020-MINSA. Directiva sanitaria para el cuidado integral de la persona afectada por tuberculosis en el contexto de la pandemia COVID-19. Available from: <a target="_blank" href="https://cdn.www.gob.pe/uploads/document/file/1437408/RM%20N%C2%B0920-2020-MINSA.PDF.PDF">https://cdn.www.gob.pe/uploads/document/file/1437408/RM%20N%C2%B0920-2020-MINSA.PDF.PDF</a>." ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Global tuberculosis control. WHO Report 2001" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "World Health Organization" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "WWW" => array:2 [ "link" => "https://apps.who.int/iris/bitstream/handle/10665/63835/WHO_CDS_TB2001.287.pdf" "fecha" => "2001" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/2529993X/0000004100000002/v1_202302081247/S2529993X23000424/v1_202302081247/en/main.assets" "Apartado" => array:4 [ "identificador" => "66012" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/2529993X/0000004100000002/v1_202302081247/S2529993X23000424/v1_202302081247/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529993X23000424?idApp=UINPBA00004N" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 5 | 1 | 6 |
| 2024 October | 16 | 1 | 17 |
| 2024 September | 12 | 2 | 14 |
| 2024 August | 10 | 1 | 11 |
| 2024 July | 15 | 4 | 19 |
| 2024 June | 18 | 2 | 20 |
| 2024 May | 13 | 1 | 14 |
| 2024 April | 18 | 2 | 20 |
| 2024 March | 15 | 9 | 24 |
| 2024 February | 15 | 1 | 16 |
| 2024 January | 10 | 1 | 11 |
| 2023 December | 11 | 2 | 13 |
| 2023 November | 7 | 4 | 11 |
| 2023 October | 21 | 10 | 31 |
| 2023 September | 7 | 0 | 7 |
| 2023 August | 1 | 1 | 2 |
| 2023 March | 1 | 3 | 4 |
| 2023 February | 1 | 0 | 1 |
Show all
